ARCHIVES

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Neulasta Reduces Incidence Of Febrile Neutropenia

February 22, 2013

In Brief: Salmon, Fidler Head ASCO, AACR; Durant, Pardee Presidents Elect; Namovicz, Other AOs Promoted

May 25, 1984

Obey Surprises Everyone, Including Himself, And Plugs For More Money For NCI, NHLBI

March 7, 1980

CHOP Training Conference Planned

January 23, 1981

In Brief: Cancer Prevention Fellowship Program Application Sought; Grant Funds Available

March 18, 1994

NIH Alternative Medicine Office Releases RFA For Grant Awards

April 9, 1993